Skip to main content
. 2013 Aug 28;9:1273–1280. doi: 10.2147/NDT.S48158

Table 1.

Summary of pretreatment demographic and baseline characteristics (intent-to-treat population)

Placebo
(n = 186)
BUP150
(n = 190)
BUP300
(n = 188)
Total
(n = 564)
Country (n)
 Japan 149 154 148 451
 South Korea 37 36 40 113
Age (years)
 Mean 37.9 36.0 37.5 37.1
 SD 11.09 10.42 10.96 10.84
 Median 37.0 35.0 36.0 36.0
 Min 20 18 21 18
 Max 63 64 64 64
Sex
 Female 101 (54%) 98 (52%) 105 (56%) 304 (54%)
 Male 85 (46%) 92 (48%) 83 (44%) 261 (46%)
Weight (kg)
 Mean 60.19 61.01 62.00 61.07
 SD 11.678 12.793 13.164 12.564
 Median 58.45 59.00 59.95 59.00
 Min 37.5 39.0 38.8 37.5
 Max 95.2 107.4 102.0 107.4
DSM-IV-TR diagnosis
 296.20 1 (<1%) 0 1 (<1%) 2 (<1%)
 296.21 0 1 (<1%) 0 1 (<1%)
 296.22 83 (45%) 84 (44%) 71 (38%) 238 (42%)
 296.23 14 (8%) 15 (8%) 11 (6%) 40 (7%)
 296.31 0 2 (1%) 0 2 (<1%)
 296.32 81 (44%) 76 (40%) 77 (41%) 234 (41%)
 296.33 7 (4%) 12 (6%) 28 (15%) 47 (8%)
Number of previous depressive episodes (not including current episode)
 0 98 (53%) 100 (53%) 83 (44%) 281 (50%)
 1 64 (34%) 56 (29%) 71 (38%) 191 (34%)
 2 12 (6%) 22 (12%) 23 (12%) 57 (10%)
 3 8 (4%) 6 (3%) 7 (4%) 21 (4%)
 4 or more 4 (2%) 6 (3%) 4 (2%) 14 (2%)
Duration of current major depressive episode(weeks)
 Mean 26.8 26.5 28.7 27.3
 SD 19.44 19.18 22.27 20.33
 Median 21.0 19.5 22.0 21.0
 Min 8 8 8 8
 Max 100 98 101 101

Notes: DSM-IV TR diagnosis code. 296.2: Major depressive disorder, single episode; 296.3: Major depressive disorder, recurrent.

Abbreviations: BUP150, bupropion SR 150 mg/day (once daily); BUP300, bupropion SR 150 mg/day (twice daily); DSM-IV-TR, Diagnostic and Statistical Manual of Mental Disorders, 4th edition, text revision; SD, standard deviation; SR, sustained release; Min, minimum; Max, maximum; n, number of subjects.